BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 2460527)

  • 1. Construction of antigen-specific suppressor T cell hybridomas from spleen cells of mice primed for the persistent IgE antibody formation.
    Iwata M; Ishizaka K
    J Immunol; 1988 Nov; 141(10):3270-7. PubMed ID: 2460527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive effects of glycosylation inhibiting factor on the IgE and IgG antibody response.
    Akasaki M; Jardieu P; Ishizaka K
    J Immunol; 1986 May; 136(9):3172-9. PubMed ID: 2937840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between T cell receptors and antigen-binding factors. I. Specificity of functional T cell receptors on mouse T cell hybridomas that produce antigen-binding T cell factors.
    Iwata M; Katamura K; Kubo RT; Ishizaka K
    J Immunol; 1989 Dec; 143(12):3909-16. PubMed ID: 2480378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of an antigen-specific T cell subset that forms IgE-suppressive factor and IgG-suppressive factor on antigenic stimulation.
    Jardieu P; Uede T; Ishizaka K
    J Immunol; 1985 Aug; 135(2):922-9. PubMed ID: 2409160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-specific T cells that form IgE-potentiating factor, IgG-potentiating factor, and antigen-specific glycosylation-enhancing factor on antigenic stimulation.
    Iwata M; Adachi M; Ishizaka K
    J Immunol; 1988 Apr; 140(8):2534-42. PubMed ID: 3258613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier-specific suppression of antibody responses by antigen-specific glycosylation-inhibiting factors.
    Jardieu P; Akasaki M; Ishizaka K
    J Immunol; 1987 Mar; 138(5):1494-501. PubMed ID: 3492554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of glycosylation-inhibiting factor with plasma membranes of T suppressor cell hybridomas.
    Iwata M; Katamura K; Mori A; Yamagushi K; Grey H; Ishizaka K
    J Immunol; 1990 Dec; 145(11):3578-88. PubMed ID: 2147196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgE-binding factors from mouse T lymphocytes. III. Role of antigen-specific suppressor T cells in the formation of IgE-suppressive factor.
    Jardieu P; Uede T; Ishizaka K
    J Immunol; 1984 Dec; 133(6):3266-73. PubMed ID: 6208275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgE-binding factors from mouse T lymphocytes. II. Strain differences in the nature of IgE-binding factor.
    Uede T; Ishizaka K
    J Immunol; 1984 Jul; 133(1):359-67. PubMed ID: 6609987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical characterization of antigen-specific glycosylation-inhibiting factor from antigen-specific suppressor T cells. I. Identification of a 55-kilodalton glycosylation-inhibiting factor peptide with TCR alpha-chain determinant.
    Nakano T; Ishii Y; Ishizaka K
    J Immunol; 1996 Mar; 156(5):1728-34. PubMed ID: 8596020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between T cell receptors and antigen-binding factors. II. Common antigenic determinants and epitope recognition shared by T cell receptors and antigen-binding factors.
    Iwata M; Katamura K; Kubo RT; Grey HM; Ishizaka K
    J Immunol; 1989 Dec; 143(12):3917-24. PubMed ID: 2480379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory effects of human IgE-binding factors on the IgE response of rat lymphocytes.
    Huff TF; Jardieu P; Ishizaka K
    J Immunol; 1986 Feb; 136(3):955-62. PubMed ID: 3079805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the biologic activities of IgE-binding factor. V. The role of glycosylation-enhancing factor and glycosylation-inhibiting factor in determining the nature of IgE-binding factors.
    Iwata M; Huff TF; Ishizaka K
    J Immunol; 1984 Mar; 132(3):1286-93. PubMed ID: 6363537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of certain epitope specificities of glycosylation inhibiting factor for the suppression of in vivo IgE and IgG antibody responses.
    Yamaguchi K; Mori A; Ohno H; Tagaya Y; Ishizaka K
    Int Immunol; 1992 Mar; 4(3):337-46. PubMed ID: 1373642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro modulation of antigen-primed T cells by a glycosylation-inhibiting factor that regulates the formation of antigen-specific suppressive factors.
    Iwata M; Ishizaka K
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2444-8. PubMed ID: 2951740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical characterization of antigen-specific glycosylation-inhibiting factor from antigen-specific suppressor T cells. II. The 55-kDa glycosylation-inhibiting factor peptide is a derivative of TCR alpha-chain and a subunit of antigen-specific glycosylation-inhibiting factor.
    Ishii Y; Nakano T; Ishizaka K
    J Immunol; 1996 Mar; 156(5):1735-42. PubMed ID: 8596021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of IgE-binding factors by rat T lymphocytes. VI. Cellular mechanisms for the formation of IgE-potentiating factor and IgE-suppressive factor by antigenic stimulation of antigen-primed spleen cells.
    Uede T; Ishizaka K
    J Immunol; 1982 Oct; 129(4):1391-7. PubMed ID: 6980933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of IgE synthesis in mouse plasma cells and B cells by rat IgE-suppressive factor.
    Uede T; Huff TF; Ishizaka K
    J Immunol; 1984 Aug; 133(2):803-8. PubMed ID: 6610711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive activities of recombinant glycosylation-inhibiting factor mutants.
    Tomura T; Watarai H; Honma N; Sato M; Iwamatsu A; Kato Y; Kuroki R; Nakano T; Mikayama T; Ishizaka K
    J Immunol; 1999 Jan; 162(1):195-202. PubMed ID: 9886386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgE-binding factors and regulation of the IgE antibody response.
    Ishizaka K
    Annu Rev Immunol; 1988; 6():513-34. PubMed ID: 3289576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.